Skip to content

The Effect of LSVT LOUD for Mandarin-speaking Individuals With Hypokinetic Dysarthria Due to Parkinson's Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02506205
Enrollment
40
Registered
2015-07-23
Start date
2014-10-31
Completion date
2015-12-31
Last updated
2015-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypokinetic Dysathria

Brief summary

A handful of studies have examined the effects of the Lee Silverman Voice Treatment (LSVT) LOUD on hypokinetic dysarthria in English speakers with Parkinson's disease (PD). Although LSVT LOUD has been found to be effective on improving these speaker's vocal intensity and increasing their speech intelligibility as well as speech function with Phase I evidence, no study has investigated whether Mandarin-speaking individuals with dysarthria secondary to PD would benefit from LSVT LOUD. In the proposed study, speech data of Mandarin-speaking individuals with hypokinetic dysarthria before and after speech therapy will be audio recorded and analyzed in order to examine the effects of LSVT LOUD on the speech function in this population. The same speech data will be played to Mandarin listeners in order to investigate the speech intelligibility of this population. It is hypothesized that Mandarin-speaking individuals with hypokinetic dysarthria secondary to PD will demonstrate reduced vocal intensity, reduced speech intelligibility and impaired speech function before they receive LSVT LOUD. They will improve these speech characteristics following speech therapy and will present with short-term maintenance effects.

Interventions

BEHAVIORALLee Silverman Voice Treatment (SVLT) LOUD

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Mandarin-speaking Taiwanese 2. Hypokinetic dysarthria due to Parkinson's disease 3. No other neurodegenerative diseases 4. No cognitive deficits 5. Age range 30 years and above

Exclusion criteria

1. Not able to follow verbal directions, 2. speech characteristics uncommon to Parkinson's disease

Design outcomes

Primary

MeasureTime frameDescription
Speech intelligibilityImmediateSpeech intelligibility will be assessed by native Mandarin listeners' orthographic transcription accuracy and ratings based on a nine-point Likert scale (from 1 - very difficult to understand to 9 - very easy to understand).

Secondary

MeasureTime frameDescription
Speech functionImmdediateSpeech function will be assessed using acoustic methods. E.g., vowel formant frequencies correlated with vowel articulation will be extracted and analyzed using Praat software.

Other

MeasureTime frameDescription
Quality of life measured by PDQ-39ImmediateThis area of assessment will be measured by Parkinson's Disease Questionnaire (PDQ-39) (Jenkinson, Fitzpatrick, Peto, Greenhall, & Hyman, 1997). This battery provides information on areas that affect participants' well-being and the degree affected.
Depression level measured by BDI-IIImmediateSome patients with PD develop depression that affects their daily life. Therefore, it is necessary to assess their depression level with Beck Depression Inventory-II (Beck, Steer, & Brown, 1996)
Cognitive status measured by MMSEImmediateIt is necessary to assess their cognitive status with Mini-mental State Examination (MMSE) (Folstein, Foistein, & McHugh, 1975) and the score will be used as the inclusion or exclusion criteria.

Countries

Taiwan

Contacts

Primary ContactRuei-Meei Wu
886-2-2312345
Backup ContactWen-Chieh Yang
886-2-33668149

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026